Cargando…

The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks

Allogeneic Hematopoietic stem cell transplantation (HSCT) is the most effective therapy to prevent relapse in acute lymphocytic leukemia (ALL). This benefit is affected by non-relapse mortality (NRM) due to complications such as graft versus host disease (GVHD). A new approach in analyzing time-depe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalali, Arash, Alimoghaddam, Kamran, Mahmoudi, Mahmood, Mohammad, Kazem, Mousavi, Seied Asadollah, Bahar, Babak, Vaezi, Mohammad, Zeraati, Hojjat, Jahani, Mohammad, Ghavamzadeh, Ardeshir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003436/
https://www.ncbi.nlm.nih.gov/pubmed/24800032
_version_ 1782313849764970496
author Jalali, Arash
Alimoghaddam, Kamran
Mahmoudi, Mahmood
Mohammad, Kazem
Mousavi, Seied Asadollah
Bahar, Babak
Vaezi, Mohammad
Zeraati, Hojjat
Jahani, Mohammad
Ghavamzadeh, Ardeshir
author_facet Jalali, Arash
Alimoghaddam, Kamran
Mahmoudi, Mahmood
Mohammad, Kazem
Mousavi, Seied Asadollah
Bahar, Babak
Vaezi, Mohammad
Zeraati, Hojjat
Jahani, Mohammad
Ghavamzadeh, Ardeshir
author_sort Jalali, Arash
collection PubMed
description Allogeneic Hematopoietic stem cell transplantation (HSCT) is the most effective therapy to prevent relapse in acute lymphocytic leukemia (ALL). This benefit is affected by non-relapse mortality (NRM) due to complications such as graft versus host disease (GVHD). A new approach in analyzing time-dependent covariates in competing risks is landmark analysis. So, the aim of this study is to evaluate the effect of acute and chronic GVHD on long-term outcomes, relapse and NRM, after allogeneic HSCT in adult ALL using landmark analysis. This study was conducted on 252 ALL patients who were allogeneic transplanted from an HLA-identical sibling with peripheral blood (PB) as the source of stem cell from 2004 to 2012 and were followed-up until 2013. In the first 100 days after transplant, a landmark analysis on days +10, +11, +12, +17, +24, and +31 was applied to assess the effect of acute GVHD on early relapse and NRM. Similarly, for patients alive and event-free at day +100 after transplant, a landmark analysis at time points day +101, months +4, +5, +6, +9, and +12 was applied to evaluate the effect of chronic GVHD on late relapse and NRM. Five-year LFS and OS were 35.0% (95% CI: 29.1, 42.2%) and 37.5% (95% CI: 31.3, 45.0%), respectively. Five-year cumulative incidence of relapse was 44.5% (95% CI: 37.9, 51.0%) while this was 20.4% (95% CI: 15.4, 26.0%) for NRM. The landmark analysis in the first 100 days after transplant showed that the grade III/IV of aGVHD has a lower risk of relapse but higher risk of NRM after adjustment for the EBMT risk score. For patients alive at day +100, cGVHD had no significant effect on relapse. Limited cGVHD had lower risk of NRM and after 6 month post-transplant the risk of NRM decreased and there were not important difference between the groups of cGVHD. Using advanced models enables us to estimate the effects more precisely and ultimately make inference more accurately.
format Online
Article
Text
id pubmed-4003436
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-40034362014-05-05 The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks Jalali, Arash Alimoghaddam, Kamran Mahmoudi, Mahmood Mohammad, Kazem Mousavi, Seied Asadollah Bahar, Babak Vaezi, Mohammad Zeraati, Hojjat Jahani, Mohammad Ghavamzadeh, Ardeshir Int J Hematol Oncol Stem Cell Res Original Article Allogeneic Hematopoietic stem cell transplantation (HSCT) is the most effective therapy to prevent relapse in acute lymphocytic leukemia (ALL). This benefit is affected by non-relapse mortality (NRM) due to complications such as graft versus host disease (GVHD). A new approach in analyzing time-dependent covariates in competing risks is landmark analysis. So, the aim of this study is to evaluate the effect of acute and chronic GVHD on long-term outcomes, relapse and NRM, after allogeneic HSCT in adult ALL using landmark analysis. This study was conducted on 252 ALL patients who were allogeneic transplanted from an HLA-identical sibling with peripheral blood (PB) as the source of stem cell from 2004 to 2012 and were followed-up until 2013. In the first 100 days after transplant, a landmark analysis on days +10, +11, +12, +17, +24, and +31 was applied to assess the effect of acute GVHD on early relapse and NRM. Similarly, for patients alive and event-free at day +100 after transplant, a landmark analysis at time points day +101, months +4, +5, +6, +9, and +12 was applied to evaluate the effect of chronic GVHD on late relapse and NRM. Five-year LFS and OS were 35.0% (95% CI: 29.1, 42.2%) and 37.5% (95% CI: 31.3, 45.0%), respectively. Five-year cumulative incidence of relapse was 44.5% (95% CI: 37.9, 51.0%) while this was 20.4% (95% CI: 15.4, 26.0%) for NRM. The landmark analysis in the first 100 days after transplant showed that the grade III/IV of aGVHD has a lower risk of relapse but higher risk of NRM after adjustment for the EBMT risk score. For patients alive at day +100, cGVHD had no significant effect on relapse. Limited cGVHD had lower risk of NRM and after 6 month post-transplant the risk of NRM decreased and there were not important difference between the groups of cGVHD. Using advanced models enables us to estimate the effects more precisely and ultimately make inference more accurately. Tehran University of Medical Sciences 2014 /pmc/articles/PMC4003436/ /pubmed/24800032 Text en © 2014 Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Jalali, Arash
Alimoghaddam, Kamran
Mahmoudi, Mahmood
Mohammad, Kazem
Mousavi, Seied Asadollah
Bahar, Babak
Vaezi, Mohammad
Zeraati, Hojjat
Jahani, Mohammad
Ghavamzadeh, Ardeshir
The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
title The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
title_full The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
title_fullStr The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
title_full_unstemmed The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
title_short The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
title_sort effect of gvhd on long-term outcomes after peripheral blood allogeneic stem cell transplantation from an hla-identical sibling in adult acute lymphocytic leukemia: a landmark analysis approach in competing risks
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003436/
https://www.ncbi.nlm.nih.gov/pubmed/24800032
work_keys_str_mv AT jalaliarash theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT alimoghaddamkamran theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT mahmoudimahmood theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT mohammadkazem theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT mousaviseiedasadollah theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT baharbabak theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT vaezimohammad theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT zeraatihojjat theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT jahanimohammad theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT ghavamzadehardeshir theeffectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT jalaliarash effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT alimoghaddamkamran effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT mahmoudimahmood effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT mohammadkazem effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT mousaviseiedasadollah effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT baharbabak effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT vaezimohammad effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT zeraatihojjat effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT jahanimohammad effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks
AT ghavamzadehardeshir effectofgvhdonlongtermoutcomesafterperipheralbloodallogeneicstemcelltransplantationfromanhlaidenticalsiblinginadultacutelymphocyticleukemiaalandmarkanalysisapproachincompetingrisks